title: Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura.
authors.forename: Masato
authors.initials: M
authors.lastname: Yagita
authors.forename: Masahito
authors.initials: M
authors.lastname: Uemura
authors.forename: Takefumi
authors.initials: T
authors.lastname: Nakamura
authors.forename: Akane
authors.initials: A
authors.lastname: Kunitomi
authors.forename: Masanori
authors.initials: M
authors.lastname: Matsumoto
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Fujimura
mesh_terms: D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; D000368:Aged; D001663:Bilirubin / Q000097:blood; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008103:Liver Cirrhosis / Q000821:virology*; D008297:Male; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000097:blood*; D010951:Plasma Exchange; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood* / Q000628:therapy; D012016:Reference Values; D016896:Treatment Outcome
chemical_list: D007770:L-Lactate Dehydrogenase; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human; D001663:Bilirubin